Teva’s Clinical Stage Acceptance Process

Initial Screening: When you submit your non-confidential information to us, we’ll initiate our review and respond to you within two weeks.

Submission of Complete Product Package: If your product meets our criteria, we’ll ask you to enter into a confidentiality agreement and submit a complete product package. If you’d like to request a confidentiality agreement template or submit your own draft, please contact your dedicated partnering officer.

Next Steps: Once we receive your confidential product package we will mutually agree on a time schedule for additional review, due diligence and business negotiations.

For earlier-stage projects, you can also review our pre-clinical stage process.

Legal Note Copyright © 1999 - 2009 Teva. All rights reserved.